SIG-M5Homo sapiens (Human)Cancer cell line

Also known as: SIGM5, SigM5

🤖 AI SummaryBased on 8 publications

Quick Overview

SIG-M5 is a human monoblastic cell line derived from AML M5a, known for its sensitivity to arsenic trioxide.

Detailed Summary

SIG-M5 is a human monoblastic cell line established from a patient with acute myeloid leukemia (AML) of the M5a subtype. It exhibits unique characteristics such as sensitivity to arsenic trioxide (As2O3), distinguishing it from other monoblastic cell lines. The cell line shows distinct morphological features, including large round blasts with abundant cytoplasmic vacuoles and a lobulated nucleus. SIG-M5 is widely used in research for studying leukaemogenesis, monocyte differentiation, and the effects of arsenic compounds on monoblastic cells. Its sensitivity to arsenic trioxide makes it a valuable model for investigating potential therapeutic strategies for monoblastic leukemias.

Research Applications

LeukaemogenesisMonocyte differentiationArsenic trioxide sensitivityMonoblastic leukemia research

Key Characteristics

Sensitivity to arsenic trioxideDistinct morphological featuresExpression of specific surface markers
Generated on 6/17/2025

Basic Information

Database IDCVCL_1694
SpeciesHomo sapiens (Human)
Tissue SourceBone marrow[UBERON:UBERON_0002371]

Donor Information

Age63
Age CategoryAdult
SexMale

Disease Information

DiseaseAcute myeloid leukemia
LineageMyeloid
SubtypeAcute Monoblastic/Monocytic Leukemia
OncoTree CodeAMOL

DepMap Information

Source TypeDSMZ
Source IDACH-000112_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleBRAFp.Val600Glu (c.1799T>A)Unspecified-PubMed=26214590

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
12
D13S317
11,12
D16S539
11,12
D18S51
15,16,18
D19S433
13,14
D21S11
29,32.2
D2S1338
19,20
D3S1358
18
D5S818
11,13
D7S820
9,11
D8S1179
14,16
FGA
22,26
Penta D
10,13
Penta E
7,19
TH01
7,9.3
TPOX
8,11
vWA
17,19
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Screening human cell lines for viral infections applying RNA-Seq data analysis.

Uphoff C.C., Pommerenke C., Denkmann S.A., Drexler H.G.

PLoS ONE 14:E0210404-E0210404(2019).

Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines.

Yang H.H., Koeffler H.P.

BMC Cancer 18:940.1-940.13(2018).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.

Quentmeier H., MacLeod R.A.F., Zaborski M., Drexler H.G.

Leukemia 20:471-476(2006).

Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations.

Fioretos T.

Leukemia 19:1042-1050(2005).

Establishment and characterization of an arsenic-sensitive monoblastic leukaemia cell line (SigM5).

Calandra T., Joller-Jemelka H.I., Fehr J., Schaffner A.

Br. J. Haematol. 109:396-404(2000).